Alain Ravaud

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Venues

Journal for immunotherapy of cancer

Cancer management and research

Therapeutics and clinical risk management

Université Bordeaux Segalen

Université Bordeaux Segalen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université Bordeaux Segalen Sep 01 2002

France

Pofessor of Oncology :: Health

Centre Hospitalier Universitaire de Bordeaux Sep 01 2002

France

Head :: Department of Medical Oncology

Education History

Université Bordeaux Segalen Jun 23 1998

France

PHD :: Biological and health Science

Publications

Julius Strauss, Jean-Laurent Deville, Mario Sznol, Alain Ravaud, Marco Maruzzo, Russell K Pachynski, Theodore S Gourdin, Michele Maio, Luc Dirix, Jeffrey Schlom, Renee N Donahue, Yo-Ting Tsai, XiaoZhe Wang, Yulia Vugmeyster, Frank Beier, Joerg Seebeck, Andreas Schroeder, Sarah Chennoufi, James L Gulley
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma. Journal for immunotherapy of cancer 11 (5) (2023)
Manon de Vries-Brilland, Nathalie Rioux-Leclercq, Maxime Meylan, Jonathan Dauvé, Christophe Passot, Elena Spirina-Menand, Ronan Flippot, Gaëlle Fromont, Gwenaelle Gravis, Lionnel Geoffrois, Christine Chevreau, Fréderic Rolland, Ellen Blanc, Félix Lefort, Alain Ravaud, Marine Gross-Goupil, Bernard Escudier, Sylvie Negrier, Laurence Albiges
Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma. Journal for immunotherapy of cancer 11 (11) (2023)
Romain Iaxx, Felix Lefort, Charlotte Domblides, Alain Ravaud, Jean-Christophe Bernhard, Marine Gross-Goupil
An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives. Therapeutics and clinical risk management 18 (2022)
Andrea B Apolo, John A Ellerton, Jeffrey R Infante, Manish Agrawal, Michael S Gordon, Raid Aljumaily, Theodore Gourdin, Luc Dirix, Keun-Wook Lee, Matthew H Taylor, Patrick Schöffski, Ding Wang, Alain Ravaud, Juliane Manitz, Gregory Pennock, Mary Ruisi, James L Gulley, Manish R Patel
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis. Journal for immunotherapy of cancer 8 (2) (2021)
Quentin Durrechou, Charlotte Domblides, Baptiste Sionneau, Felix Lefort, Amandine Quivy, Alain Ravaud, Marine Gross-Goupil, Amaury Daste
Management of Immune Checkpoint Inhibitor Toxicities. Cancer management and research 12 (2020)

Alain Ravaud.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alain Ravaud